Abstract

China once suffered greatly from schistosomiasis japonica, a major zoonotic disease. Nearly 70 years of multidisciplinary efforts have achieved great progress in disease control, with infections in both humans and bovines significantly reduced to very low levels. However, reaching for the target of complete interruption of transmission at the country level by 2030 still faces great challenges, with areas of ongoing endemicity and/or re-emergence within previously 'eliminated' regions. The objectives of this study were, by using meta-analytical methods, to estimate the overall prevalence of Schistosoma japonicum infections in abundant commensal rodent species in mainland China after the introduction of praziquantel for schistosomiasis treatment in humans and bovines in 1980s. In doing so we thereby aimed to further assess the role of wild rodents as potential reservoirs in ongoing schistosome transmission. Published studies on infection prevalence of S. japonicum in wild rodents in mainland China since 1980 were searched across five electronic bibliographic databases and lists of article references. Eligible studies were selected based on inclusion and exclusion criteria. Risks of within and across study biases, and the variations in prevalence estimates attributable to heterogeneities were assessed. The pooled infection prevalence and its 95% confidence intervals (CIs) were calculated with the Freeman-Tukey double arcsine transformation. We identified a total of 37 relevant articles involving 61 field studies which contained eligible data on 8,795 wild rodents across mainland China. The overall pooled infection prevalence was 3.86% (95% CI: 2.16-5.93%). No significant change in the overall pooled prevalence was observed between 1980-2003 (n = 23 studies) and 2004-current (n = 38 studies). However, whilst the estimated prevalence decreased over time in the marshland and lake regions, there was an apparent increase in prevalence within hilly and mountainous regions. Among seven provinces, a significant prevalence reduction was only seen in Jiangsu where most endemic settings are classified as the marshland and lakes. These estimates changed over season, ranging from 0.58% in spring to 22.39% in winter, in association with increases in rodent density. This study systematically analyzed S. japonicum infections in wild rodents from the published literature over the last forty years after the introduction of praziquantel for schistosomiasis treatment in humans and bovines in 1980s. Although numbers of schistosomiasis cases in humans and bovines have been greatly reduced, no such comparable overall change of infection prevalence in rodents was detected. Furthermore, there appeared to be an increase in S. japonicum prevalence in rodents over time within hilly and mountainous regions. Rodents have been projected to become the dominant wildlife in human-driven environments and the main reservoir of zoonotic diseases in general within tropical zones. Our findings thus suggest that it is now necessary to include monitoring and evaluation of potential schistosome infection within rodents, particularly in hilly and mountainous regions, if we are ever to reach the new 2030 elimination goals and to maximize the impact of future public, and indeed One Health, interventions across, regional, national and international scales.

Highlights

  • Schistosomiasis is the second most important parasitic disease after malaria, in terms of socioeconomic impact, and is endemic in 78 tropical and subtropical countries

  • The majority of human infections and morbidity are caused by three main schistosome species: Schistosoma mansoni, S. haematobium, and S. japonicum [2], among which S. japonicum is the only human blood fluke that is endemic in China [3]

  • This study systematically analyzed the available literature on S. japonicum infections in rodents over the last forty years after the introduction of praziquantel for schistosomiasis treatment in humans and livestock

Read more

Summary

Introduction

Schistosomiasis is the second most important parasitic disease after malaria, in terms of socioeconomic impact, and is endemic in 78 tropical and subtropical countries. The majority of human infections and morbidity are caused by three main schistosome species: Schistosoma mansoni, S. haematobium, and S. japonicum [2], among which S. japonicum is the only human blood fluke that is endemic in China [3]. At the beginning of the national schistosomiasis control programme in the 1950’s, approximately 100 million Chinese people (of a total population of approximately 600 million) were at risk of schistosome infection, and an estimated 11.612 million people were infected [5]. 70 years of integrated multi-disciplinary control efforts, including mass drug administration (MDA) of praziquantel (PZQ) to both humans and bovine hosts since the 1980s [6], has achieved tremendous progress in reducing prevalence and intensity levels of human and bovine schistosomiasis [7]. China, consistent with the revised WHO Global Goals, has set the target of complete interruption of transmission (elimination) of zoonotic S. japonicum by 2030 at the entire country level [9]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call